Samsung Medical Center
Seoul, South Korea
Location status: Recruiting
NCT Number: NCT03637569
In this study, the investigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Seoul, South Korea
Location status: Recruiting
Cachexia is frequently seen in pancreatic cancer(70-80%) and associated with reduced survival, reduced treatment tolerance and reduction in QoL. In recent studies, low-normal BMI have worse outcome (overall mortality) in cardiovascular, malignant, chronic disease (So called "obesity paradox") BMI is simple method but hard to define body composition because BMI is based on only weight and height. Skinfold thickness is strongly associated with body fatness than BMI. In this study, the ivestigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
By using skin thickness caliper, measure triceps skinfold thickness on the half of forearm (Rt side). In every 3 weeks, triceps skinfold thickness will be measured.
Time frame: through study completion, an average of 2 year
The duration between diagnosis and death
Contact information is provided by the study sponsor or research team.
Samsung Medical Center
Other
The Relationship Between Triceps Skinfold and Overall Survival of Pancreatic Cancer, Cholangiocarcinoma and Gallbladder Cancer.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01915225
Adenocarcinoma, Bile Duct Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT04907643
Adenocarcinoma, Ampullary Cancer
Los Angeles, California, United States
View Trial DetailsNCT06126406
Adenocarcinoma, Breast Cancer
Wuhu, Anhui, China
View Trial DetailsNCT06010862
Adenocarcinoma, Breast Cancer
Nanchang, Jiangxi, China
View Trial Details